Impact of Dietary Diversity on Postprandial Insulin Secretion and Metabolism
This randomized, controlled, crossover dietary intervention will test whether a three-week diverse diet, compared with a control diet with lower food diversity, changes postprandial insulin responses, other metabolic parameters, and the gut microbiome in 34 healthy adults with overweight. Participants will complete both diets in a randomized order, separated by a four-week washout period. The intervention periods will be conducted under free-living conditions, with study foods provided by the research center. Before and after each intervention period, postprandial metabolism will be assessed using standardized meal tests conducted under controlled whole-room calorimetry conditions. The primary outcome is the log-transformed total postprandial insulin area under the concentration-time curve from 0 to 240 minutes.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Anja Bosy-Westphal, Prof. Dr. Dr.
- Phone Number: +49 431 880 5674
- Email: abosyw@nutrition.uni-kiel.de
Study Locations
-
-
Schleswig-Holstein
-
Kiel, Schleswig-Holstein, Germany, 24105
- Institute of Human Nutrition and Food Science , Department Human Nutrition
-
Contact:
- Anja Bosy-Westphal
- Phone Number: +49 431 880 5674
- Email: abosyw@nutrition.uni-kiel.de
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy adults with overweight.
- Age 18-60 years.
- Body mass index (BMI) >=25 and <30 kg/m2.
- Men and women; the study plans an equal distribution of biological sex.
- No regular sports participation; regular sporting activity >=2 h/week is excluded.
- German-speaking, because the study questionnaires are in German and not validated in other languages.
- No anemia or iron deficiency based on screening hemoglobin and ferritin.
- Women of childbearing potential must use hormonal contraception (e.g., pill, hormonal IUD, contraceptive patch, vaginal ring, 3-month injection, or hormonal implant) and have pregnancy excluded by hCG testing.
- Able and willing to provide written informed consent.
Exclusion Criteria:
- - Individuals unable to provide informed written consent.
- Vegetarian or vegan diet.
- Habitual consumption of more than 5 caffeinated beverages per day.
- Chronic diseases.
- Regular medication use, except oral contraceptives.
- Antibiotic use within 6 weeks before study start.
- Anemia and/or iron deficiency.
- Pregnancy or breastfeeding.
- Cigarette and/or cannabis use, including vaping.
- Food allergies and/or food intolerances.
- Current weight-reduction diet or weight loss >5 kg within the previous 3 months.
- Regular sporting activity >=2 h/week.
- Claustrophobia/fear of confined spaces because of EchoMRI assessment.
- Active participation in another study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Control Diet -> Diverse Diet
|
Three-week controlled free-living diet with low diversity of plant foods, lower diversity/content of fiber types and polyphenols, fewer fermented foods, and at least 50% of energy from ultra-processed foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to a diverse diet. Three-week controlled free-living diet with a wide variety of minimally processed plant foods, different fiber types and polyphenol sources, and regularly consumed fermented foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to the control diet. |
|
Experimental: Diverse Diet -> Control Diet
|
Three-week controlled free-living diet with low diversity of plant foods, lower diversity/content of fiber types and polyphenols, fewer fermented foods, and at least 50% of energy from ultra-processed foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to a diverse diet. Three-week controlled free-living diet with a wide variety of minimally processed plant foods, different fiber types and polyphenol sources, and regularly consumed fermented foods. The diet is designed to follow German Nutrition Society recommendations and to be as comparable as possible to the control diet. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postprandial Insulin
Time Frame: 0-240 minutes
|
fasting, iAUC, tAUC, peak - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postprandial Glucose
Time Frame: 0-240 minutes
|
fasting, iAUC, tAUC, peak - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
C-Peptide
Time Frame: 24 hours
|
Urinary c-peptide excretion during the 24h stay in the whole-room indirect calorimeter. |
24 hours
|
|
Non-esterified fatty acids
Time Frame: 0-240 minutes
|
fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
Triglycerides
Time Frame: 0-240 minutes
|
fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
Appetite-relatied hormones (GLP-1, PYY, Ghrelin)
Time Frame: 0-240 minutes
|
fasting, iAUC, tAUC - measured using a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
0-240 minutes
|
|
Subjective Appetite
Time Frame: 0-300 minutes
|
measured with visual analogue scales (5 hours AUC; mm x 5 hours) after a meal test conducted in a whole-room indirect calorimeter at the beginning and end of each three-week intervention period, i.e., twice per intervention. The scale consists of a 10 cm vertical line anchored with "not hungry at all" at the left side and with "extremely hungry" at the right side. |
0-300 minutes
|
|
Energy Expenditure and macronutrient oxidation
Time Frame: 24 hours
|
measured during the 24h stay with indirect calorimetry in a whole-room indirect calorimeter (kcal/day) at the beginning and end of each three-week intervention period, i.e., twice per intervention. |
24 hours
|
|
Gut microbiome composition and Microbiome diversity
Time Frame: Baseline, after 1 week in the intervention (day 8), after the 3-week intervention (day 21) - in both arms.
|
taxonomy and function via shotgun metagenome sequencing |
Baseline, after 1 week in the intervention (day 8), after the 3-week intervention (day 21) - in both arms.
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- ABW-2026-GRK
- 54453043/GRK3128 (Other Grant/Funding Number: DFG)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.